Cosmos Health Inc. (COSM) Financial Statements (2024 and earlier)
Company Profile
Business Address |
5 AGIOU GEORGIOU, PILEA THESSALONIKI, 55438 |
State of Incorp. | NV |
Fiscal Year End | December 31 |
Industry (SIC) | 5122 - Drugs, Drug Proprietaries, and Druggists' Sundries (benchmarking) |
More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) ($ in thousands)
9/30/2023 MRQ | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | 12/31/2017 | |||
---|---|---|---|---|---|---|---|---|---|
ASSETS | |||||||||
Current Assets | |||||||||
Cash, cash equivalents, and short-term investments | 20,765 | 293 | 851 | 277 | 864 | 783 | |||
Cash and cash equivalents | 20,750 | 286 | 628 | 39 | 864 | 783 | |||
Short-term investments | 15 | 7 | 223 | 239 | |||||
Receivables | 4,943 | 1,427 | |||||||
Inventory, net of allowances, customer advances and progress billings | 3,452 | 3,147 | 3,293 | 3,474 | 3,203 | 3,094 | |||
Inventory | 3,452 | 3,147 | 3,293 | 3,474 | 3,203 | 3,094 | |||
Prepaid expense | 1,663 | 1,482 | |||||||
Intangible current assets | 212 | ||||||||
Other undisclosed current assets | 31,828 | 37,438 | 36,629 | 17,427 | 7,463 | 2,725 | |||
Total current assets: | 56,045 | 40,879 | 40,773 | 21,179 | 18,347 | 9,511 | |||
Noncurrent Assets | |||||||||
Finance lease, right-of-use asset, after accumulated amortization | 292 | 167 | ✕ | ✕ | |||||
Operating lease, right-of-use asset | 821 | 498 | ✕ | ✕ | |||||
Property, plant and equipment | 1,817 | 1,881 | 1,757 | 1,735 | 1,426 | 115 | |||
Intangible assets, net (including goodwill), including: | 707 | 493 | 231 | 264 | 297 | 42 | |||
Goodwill | 50 | 50 | 50 | (14) | |||||
Intangible assets, net (excluding goodwill) | 657 | 443 | 181 | 214 | 201 | ||||
Other undisclosed intangible assets, net (including goodwill) | 50 | 110 | 42 | ||||||
Other undisclosed noncurrent assets | 8,357 | 6,177 | 1,084 | 37 | 625 | 1,009 | |||
Total noncurrent assets: | 11,994 | 8,551 | 3,071 | 2,701 | 2,348 | 1,165 | |||
TOTAL ASSETS: | 68,039 | 49,429 | 43,844 | 23,880 | 20,695 | 10,676 | |||
LIABILITIES AND EQUITY | |||||||||
Liabilities | |||||||||
Current Liabilities | |||||||||
Accounts payable and accrued liabilities, including: | 276 | 2,345 | 11,974 | 8,562 | 9,769 | 11,311 | |||
Taxes payable | ✕ | ✕ | 1,325 | 760 | 176 | 1,359 | |||
Accounts payable | 9,804 | 9,952 | |||||||
Accrued liabilities | 276 | 1,020 | 742 | (35) | |||||
Other undisclosed accounts payable and accrued liabilities | 10,471 | 8,386 | |||||||
Debt | 97 | 5,902 | 13,285 | 13,254 | 136 | 122 | |||
Other liabilities | 862 | 1,256 | 339 | 165 | 111 | ||||
Due to related parties | ✕ | 11,930 | 464 | 1,629 | 1,376 | 1,793 | 98 | ||
Other undisclosed current liabilities | 8,584 | 19,962 | 7,566 | 4,885 | 10,465 | 2,173 | |||
Total current liabilities: | 21,749 | 29,928 | 34,793 | 28,241 | 22,274 | 13,704 | |||
Noncurrent Liabilities | |||||||||
Long-term debt and lease obligation | 3,066 | 1,322 | 779 | 436 | |||||
Long-term debt, excluding current maturities | 2,860 | 478 | |||||||
Finance lease, liability | 206 | 148 | 188 | 83 | ✕ | ✕ | |||
Liabilities, other than long-term debt | 2,012 | 568 | 109 | ||||||
Other liabilities | 1,359 | 107 | 109 | ||||||
Operating lease, liability | 654 | 696 | 591 | 353 | ✕ | ✕ | |||
Derivative instruments and hedges, liabilities | 461 | ||||||||
Other undisclosed noncurrent liabilities | 1,555 | 13,103 | 11,866 | 1,555 | 1,738 | ||||
Total noncurrent liabilities: | 6,633 | 15,122 | 13,212 | 2,099 | 1,738 | ||||
Total liabilities: | 28,382 | 45,050 | 48,005 | 30,340 | 24,012 | 13,704 | |||
Equity | |||||||||
Equity, attributable to parent, including: | 39,284 | 4,379 | (4,161) | (6,461) | (3,317) | (3,028) | |||
Preferred stock | 372 | ||||||||
Common stock | 11 | 18 | 13 | 13 | 14 | 13 | |||
Treasury stock, value | (817) | (817) | 612 | 412 | (225) | (96) | |||
Common stock, share subscribed but unissued, subscriptions receivable | (4,750) | ||||||||
Additional paid in capital | 112,206 | 39,676 | 14,333 | 13,526 | 13,134 | 5,652 | |||
Accumulated other comprehensive income (loss) | (1,133) | (152) | 855 | (16) | 33 | (1,385) | |||
Accumulated deficit | (66,233) | (34,346) | (18,751) | (19,572) | (16,273) | (7,212) | |||
Other undisclosed equity, attributable to parent | (372) | (1,224) | (824) | ||||||
Other undisclosed equity | 372 | ||||||||
Total equity: | 39,657 | 4,379 | (4,161) | (6,461) | (3,317) | (3,028) | |||
TOTAL LIABILITIES AND EQUITY: | 68,039 | 49,429 | 43,844 | 23,880 | 20,695 | 10,676 |
Income Statement (P&L) ($ in thousands)
9/30/2023 TTM | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | 12/31/2017 | ||
---|---|---|---|---|---|---|---|---|
Revenues | 50,348 | 56,240 | 55,406 | 39,676 | 37,084 | 30,013 | ||
Cost of revenue | (44,391) | (47,909) | (47,346) | (36,014) | (34,675) | (28,057) | ||
Cost of goods and services sold | (44,391) | (47,909) | (47,346) | (36,014) | ||||
Gross profit: | 5,957 | 8,330 | 8,060 | 3,662 | 2,409 | 1,956 | ||
Operating expenses | (13,431) | (12,864) | (5,346) | (3,918) | (3,637) | (6,829) | ||
Other operating expense, net (Other Expenses) | (27) | |||||||
Other undisclosed operating income | 27 | |||||||
Operating income (loss): | (7,474) | (4,533) | 2,714 | (256) | (1,228) | (4,872) | ||
Nonoperating income (expense) | (5,581) | (3,314) | 371 | (2,882) | (314) | 330 | ||
Investment income, nonoperating | (194) | 66 | ||||||
Gain (loss), foreign currency transaction, before tax | (413) | (1,007) | 305 | (141) | (314) | 330 | ||
Other nonoperating expense | (2,425) | (2,860) | ||||||
Interest and debt expense | 1,004 | (3,431) | (942) | 1,412 | (968) | (748) | ||
Income (loss) from continuing operations before equity method investments, income taxes: | (12,051) | (11,278) | 2,143 | (1,725) | (2,510) | (5,290) | ||
Other undisclosed income (loss) from continuing operations before income taxes | (1,004) | 3,431 | (945) | (1,391) | (6,533) | (917) | ||
Income (loss) from continuing operations before income taxes: | (13,055) | (7,848) | 1,198 | (3,116) | (9,043) | (6,207) | ||
Income tax expense (benefit) | (775) | 114 | (378) | 183 | (17) | (3) | ||
Income (loss) from continuing operations: | (13,830) | (7,734) | 821 | (2,933) | (9,061) | (6,210) | ||
Income (loss) before gain (loss) on sale of properties: | ✕ | ✕ | (7,734) | 821 | (2,933) | (9,061) | (6,210) | |
Other undisclosed net loss | (50,115) | (7,861) | (366) | |||||
Net income (loss): | (63,945) | (15,595) | 821 | (3,299) | (9,061) | (6,210) | ||
Other undisclosed net income attributable to parent | 50,115 | 7,633 | ||||||
Net income (loss) attributable to parent: | (13,830) | (7,962) | 821 | (3,299) | (9,061) | (6,210) | ||
Preferred stock dividends and other adjustments | (1,050) | |||||||
Net income (loss) available to common stockholders, basic: | (13,830) | (7,962) | 821 | (4,349) | (9,061) | (6,210) | ||
Other undisclosed net loss available to common stockholders, diluted | (50,115) | (7,633) | ||||||
Net income (loss) available to common stockholders, diluted: | (63,945) | (15,595) | 821 | (4,349) | (9,061) | (6,210) |
Comprehensive Income ($ in thousands)
9/30/2023 TTM | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | 12/31/2017 | ||
---|---|---|---|---|---|---|---|---|
Net income (loss): | (63,945) | (15,595) | 821 | (3,299) | (9,061) | (6,210) | ||
Other comprehensive income (loss) | (16,601) | (871) | 49 | (7,643) | (6,545) | |||
Other undisclosed comprehensive income (loss) | 1,742 | (98) | ||||||
Comprehensive income (loss): | (63,945) | (32,196) | 1,692 | (3,348) | (16,703) | (12,754) | ||
Other undisclosed comprehensive income (loss), net of tax, attributable to parent | (981) | |||||||
Comprehensive income (loss), net of tax, attributable to parent: | (64,926) | (32,196) | 1,692 | (3,348) | (16,703) | (12,754) |
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.